Literature DB >> 22827722

Tracking the naturally occurring mutations across the full-length genome of hepatitis B virus of genotype D in different phases of chronic e-antigen-negative infection.

S Ghosh1, R K Mondal, P Banerjee, M Nandi, S Sarkar, K Das, A Santra, S Banerjee, A Chowdhury, S Datta.   

Abstract

Hepatitis B e-antigen (HBeAg)-negative chronic HBV infection is highly prevalent in several parts of the world, including India, with the clinical spectrum ranging from inactive carrier (IC) state to chronic 'e-negative' hepatitis B (CHB) and culminating in advanced liver disease such as cirrhosis (LC). The present study has for the first time investigated the natural diversity of HBV belonging to genotype D in treatment-naïve Indian patients representing the above phases of HBeAg-negative infection to identify candidate mutations associated with each disease state. Studies of full-length HBV/D sequences revealed that the progressive accumulation and persistence of mutations in basal core promoter, negative regulatory element, Pre-core region, the B- and T-cell epitopes of X protein as well as deletions in the PreS region contribute significantly to disease progression from IC through CHB to LC. In addition, the development of CHB was associated with a significant increase in viral variants characterized by mutations in enhancer II, preS1 promoter, T-cell epitope of core and B-cell epitope region of PreS1. While few of the mutations were previously reported in the context of HBV genotypes B and C, others had not been documented before. Our results thus highlight a distinct pattern of mutation in HBV/D that may help in predicting clinical outcomes of HBeAg-negative infection and have implications for better clinical management of the patients.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22827722     DOI: 10.1111/j.1469-0691.2012.03975.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  13 in total

1.  CD8+ T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress.

Authors:  George F Gao; Jingmin Zhao; Yu Zhang; Yan Wu; Mengmeng Deng; Dongping Xu; Xiaodong Li; Zhihui Xu; Jun Hu; Han Zhang; Kefang Liu; Yingze Zhao; Feng Gao; Shengli Bi; William J Liu; Songdong Meng
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 2.  Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

Authors:  Mahmoud Reza Pourkarim; Samad Amini-Bavil-Olyaee; Fuat Kurbanov; Marc Van Ranst; Frank Tacke
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 3.  Hepatitis B virus genotypes: global distribution and clinical importance.

Authors:  Mustafa Sunbul
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

4.  Hepatitis B virus genotypes A and D in Uganda.

Authors:  Jackie T Zirabamuzale; Christopher K Opio; Freddie Bwanga; Emmanuel Seremba; Betty S Apica; Robert Colebunders; Ponsiano Ocama
Journal:  J Virus Erad       Date:  2016-01-01

5.  Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients.

Authors:  Ahmed A Al-Qahtani; Mashael R Al-Anazi; Nyla Nazir; Rohit Ghai; Ayman A Abdo; Faisal M Sanai; Waleed K Al-Hamoudi; Khalid A Alswat; Hamad I Al-Ashgar; Mohammed Q Khan; Ali Albenmousa; Damian Dela Cruz; Marie Fe F Bohol; Mohammed N Al-Ahdal
Journal:  Oncotarget       Date:  2017-11-06

6.  Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.

Authors:  Yeshambel Belyhun; Uwe Gerd Liebert; Melanie Maier
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

7.  Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection.

Authors:  Victoria Therese Mücke; Katja Jakobi; Viola Knop; Dominique Thomas; Marcus Maximilian Mücke; Kai-Henrik Peiffer; Stefan Zeuzem; Christoph Sarrazin; Josef Pfeilschifter; Georgios Grammatikos
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

8.  Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients.

Authors:  Somenath Datta; Shrabasti Roychoudhury; Alip Ghosh; Debanjali Dasgupta; Amit Ghosh; Bidhan Chandra Chakraborty; Bidhan Chakraborty; Sukanta Ray; Sukanta Roy; Subash Gupta; Amal Kumar Santra; Simanti Datta; Kausik Das; Gopal Krishna Dhali; Abhijit Chowdhury; Soma Banerjee
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

Review 9.  Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression.

Authors:  Yu-Min Choi; So-Young Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2018-04-28       Impact factor: 5.742

10.  Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach.

Authors:  Evangelia-Georgia Kostaki; Timokratis Karamitros; Garyfallia Stefanou; Ioannis Mamais; Konstantinos Angelis; Angelos Hatzakis; Anna Kramvis; Dimitrios Paraskevis
Journal:  Elife       Date:  2018-08-07       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.